3 WELCOME It is our great pleasure to welcome you to Stuttgart on the occasion of the 22nd EMSOS Conference along with the 10th EMSOS Symposium for Nurses and Allied Health Professionals. This year’s EMSOS conference, held Thursday May 14 and Friday 15 2009 at the Haus der Wirtschaft in downtown Stuttgart, is preceded by an interdisciplinary training course »Bone Tumors in Children and Adolescents« on Wednesday, May 13, and followed by a sarcoma-patient support meeting and meetings of the COSS, CWS, and EURO-E.W.I.N.G. sarcoma groups on Saturday, May 16. We are very pleased to announce that researchers from 32 different countries have submitted a total of over 250 scientific abstracts for presentation at the 2009 EMSOS meeting. In addition, some of Europe’s and North America’s leading experts have agreed to hold key lectures on a variety of topics relevant to all those with a special interest in bone and soft tissue tumors. Key speakers include Ronnie Barr, Hamilton, CDN, Pancras Hogendoorn, Leiden, NL, Jeremy Whelan, London, UK, Ewa Koscielniak, Stuttgart, DE and Jörg-Thomas Hartmann, Tübingen, DE. We are particularly pleased to announce that Tom DeLa- ney, Boston, USA, will present the Campanacci Lecture on Proton and Charged Particle Radiotherapy for Challenging Bone and Soft Tissue Sarcomas and Richard Gorlick, New York, USA, the EMSOS Lecture on Current Concepts on the Molecular Biology of Osteosarcoma. Putting a special emphasis on children, adolescents, and young adults, these and other speakers will examine recent advances in the fields of tumor biology, local and systemic treatments for bone and soft-tissue sarcomas, and innova- tions in quality of life and follow-up programs. While we fit a lot of scientific content into EMSOS conferences, they are not all work and no play. To get the Stuttgart conference off on the right foot, the EMSOS-Board invites you to join them for a welcome party on Wednesday, 13 May in the excellent »Plenum« restaurant which is based in the parliament building of the German federal state of Baden-Württemberg. On Thursday, 14 May, we hope you will join us for the annual EMSOS gala dinner. This year’s dinner has been given the motto »A taste of Stuttgart« and during the evening in what was formerly Germany’s largest cooperative wine press you will be able to enjoy some of the best Stuttgart wines, culinary dishes and entertainment. Stuttgart’s Lord Mayor, Dr. Wolfgang Schuster, has kindly invited those still in Stuttgart on the evening of Friday 15 May to a drinks reception at Stuttgart’s City Hall, following on from which the Allianz Insurance Company has invited us and those attending the national sarcoma survivor meeting organized by the German Childhood Cancer Foundation on the following day to a dinner at their headquarters. We would like to take this opportunity to extend our special thanks to our sponsors and exhibitors, in particular to our main sponsor Implantcast and our primary sponsors IDM, PharmaMar, and Stryker. Representatives from these and many other companies whose products we use in our clinical work will be available in the industry exhibition to talk to you during the breaks and we encourage you take this opportunity to find out their latest developments and news. On behalf of the EMSOS-Board and the local organizing committee we wish you an informative, enjoyable and useful conference. We are happy to see so many old friends amongst the list of partici- pants and we look forward to making many new ones. Yours sincerely Antonie Taminiau, EMSOS-President; Stefan Bielack, EMSOS-Vice-President and Local Organiser 4 Thymoglobuline® für erfolgreiche Immunsuppression 5IZNPHMPCVMJOF1VMWFSGSFJO,PO[FOUSBU[VS)FSTUFMMVOHFJOFS*OGVTJPOTMzTVOH8JSLTUPGG Antihuman T-Zell-Immunglobulin vom Kaninchen. Verschreibungspflichtig. ;VTBN NFOTFU[VOH Nach Auflösen des Pulvers in 5 ml Wasser für Injektionszwecke enthält 1 ml Lösung 5 mg Antihuman T-Zell-Immunglobulin vom Kaninchen. 4POTU#FTUBOEUFJMF Glycin, Mannitol, Natriumchlorid. "OXFOEVOHTHFCJFUFProphylaxe von Abstoßungskrisen nach Transplantationen von Niere, Herz, Leber und Bauchspeicheldrüse (üblicherweise in Kombination mit anderen Immunsuppressiva); Therapie von Abstoßungskrisen nach Transplantationen von Niere, Herz und Leber; Therapie der aplastischen Anämie, wenn andere Therapien versagen. (FHFOBO[FJHFOakute oder chronische Infektionen, Überempfindlichkeit gegenüber Kaninchenproteine oder gegen einen der sonstigen Bestandteile von Thymoglobuline. 8BSOIJOXFJT Vorsicht bei Vorliegen einer Thrombozytopenie oder Leukozytopenie; ggf. Reaktivierung von Infektionen bei Kombinationsgabe mit anderen Immunsuppressiva sowie erhöhtes Risiko für Krebserkrankungen inkl. Lymphome; mögl. Ausbleiben der Wirkung nach Applikation von Lebendimpfstoffen. Anwendung während Schwangerschaft und Stillzeit nur bei strenger Indikationsstellung. /FCFOXJSLVOHFOAus einer Studie: Sehr häufig: reduzierte Anzahl von weißen Blutkörperchen und Blutplätt- chen, Fieber, Infektionen. Häufig: Durchfall, Schluckbeschwerden, Übelkeit, Erbrechen, Schüttelfrost, Serumkrankheit (Ausschlag, Juckreiz, Gelenkschmerzen, Nierenprobleme, Schwellung der Lymphknoten), Muskelschmerzen, Tumore, Kurzatmigkeit, niedriger Blutdruck. Zusätzliche Meldungen nach Marktzugang: Juckender Ausschlag, Atemprobleme, Magenschmerzen, Schwellungen im Gesicht, der Zunge oder im Hals, pfeifende Atmung oder Husten, Schwindel, Ohnmachtsgefühl, Kopfschmerzen, Blutungen, Blutergüsse, unregelmäßiger oder beschleunigter Herzschlag, Halsschmerzen, Mundgeschwüre. Berichte über das Auftreten von Infektionen, Reaktivierung von Infektionen und Sepsis nach Verabreichung einer Kombination von mehreren Immunsuppressiva. Selten: Tumore und Lymphome. )JOXFJTNähere Informationen siehe Fach-/Gebrauchsinformation. 1IBSNB [FVUJTDIFS6OUFSOFINFS Genzyme Europe B.V., Gooimeer 10, 1411 DD Naarden, Niederlande. 4UBOEJuli 2008. THYMO 3/03-09 THYMO Weitere Informationen erhalten Sie über Genzyme GmbH, Siemensstr.5 b, 63263 Neu-Isenburg, Tel.: +49 (0) 6102 3674-0, Fax +49 (0) 6102 3674-600. (FO[ZNF(NC), Transplant/Oncology tSiemensstraße 5b tD-63263 Neu-Isenburg Telefon: +49 (0) 6102/3674-602 tFax +49 (0) 6102/3674-600 [email protected] 5 GENERAL INFORMATION SCIENTIFIC SESSIONS Unless otherwise stated, all of the EMSOS scientific sessions will take place in the König-Karl-Halle of the Haus der Wirtschaft. Breaks will take place in the List-Saal, which is also the venue for the poster sessions and industry exhibition. The Nurses and Allied Professionals Symposium will take place in the Karlsruhe Room. CONTINUING MEDICAL EDUCATION POINTS The Medical Council of Baden-Wuerttemberg has accredited the training course with 8 points, the EMSOS Conference with 16 points and the GPOH-Research Forum with 6 points. Visit the registration desk to sign the attendance list and pick up your certificate (please note that certificates are only valid if the list has been signed). The »Arbeitsgemeinschaft Internistische Onkologie« (AIO) has accredited the EMSOS conference with 11 AIO points. The Nurses and Allied Professionals Symposium is recognized for 9 CME points by the German Society for Voluntary Further Education. INFORMATION FOR POSTER PRESENTERS Please have your poster in place in time for the first coffee break and do not take it down until after the final coffee break on Friday afternoon. All authors are expected to be by their poster during their poster session and also to be present during the poster presentations and awards ceremony which will take place during the afternoon of Friday, 15 May. Please note that we are unable to return any posters which are left behind at the end of the conference. AWARDS CEREMONY During the awards ceremony which will take place on Friday, 15 May at 16:35 the following prizes, each to the value of 250 Euros, will be awarded: Best basic science presentation Best poster presentation Best oral presentation Best oral presentation from the Nurses and Allied Professionals Symposium Best poster presentation from the Nurses and Allied Professionals Symposium. LUGGAGE Luggage can be left in the cloakroom of the Haus der Wirtschaft on Friday 15 and Saturday 16 May from 08.00 until the close of the conference. SECURITY The Haus der Wirtschaft is a public building with open access to all and no security. We regret that we cannot be held responsible for any loss or damage which might occur to your property during the conference. INSURANCE The organisers do not accept liability for individual medical, travel or personal insurance and partici- pants have been advised to make their own arrangements with regards to insurance. The organisers reserve the right to alter or cancel, without prior notice, the conference of any arrangements relating directly or indirectly to it. The organisers shall not be liable for any loss, damage, expenditure or inconve- nience caused as result of such alterations or cancellation. The content of this program is correct at the time of publishing. However, the organisers reserve the right to alter or cancel the program if necessary. 6 Klare Informationen, immer und überall. Die netzwerkfähigen Patientenmonitore der IntelliVue-Familie liefern den Behandlungs- teams im gesamten Krankenhaus die gewünschten Informationen direkt ans Patientenbett. Einfach weil Sie uns inspirieren. www.philips.de/healthcare 7 PROGRAM OVERVIEW PROGRAM OVERVIEW SESSION TITLE TIME/VENUE WEDNESDAY, 13.05.2009 Training Day on Bone Tumors in Children and Adolescents 08:00 – 18:00 Bertha-Benz Saal Welcome party at the